Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches

NCT00172094 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00172094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00172094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
July 31, 2004
Enrollment
189 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache